DK1509241T3 - Nye anvendelser af cephaiboler - Google Patents

Nye anvendelser af cephaiboler

Info

Publication number
DK1509241T3
DK1509241T3 DK03722587T DK03722587T DK1509241T3 DK 1509241 T3 DK1509241 T3 DK 1509241T3 DK 03722587 T DK03722587 T DK 03722587T DK 03722587 T DK03722587 T DK 03722587T DK 1509241 T3 DK1509241 T3 DK 1509241T3
Authority
DK
Denmark
Prior art keywords
aib
hyp
iva
gln
phe
Prior art date
Application number
DK03722587T
Other languages
Danish (da)
English (en)
Inventor
Brigitte Schlegel
Albert Haertl
Udo Graefe
Matthias Schiell
Laszlo Vertesy
Joachim Wink
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1509241T3 publication Critical patent/DK1509241T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03722587T 2002-05-23 2003-05-02 Nye anvendelser af cephaiboler DK1509241T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10222792A DE10222792A1 (de) 2002-05-23 2002-05-23 Neue Verwendung von Cephaibolen

Publications (1)

Publication Number Publication Date
DK1509241T3 true DK1509241T3 (da) 2007-01-15

Family

ID=29414050

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03722587T DK1509241T3 (da) 2002-05-23 2003-05-02 Nye anvendelser af cephaiboler

Country Status (12)

Country Link
EP (2) EP1509241B1 (fr)
JP (1) JP2005528421A (fr)
AT (1) ATE336259T1 (fr)
AU (1) AU2003229766A1 (fr)
BR (1) BR0311238A (fr)
CA (1) CA2487246A1 (fr)
DE (2) DE10222792A1 (fr)
DK (1) DK1509241T3 (fr)
ES (1) ES2271575T3 (fr)
MX (1) MXPA04011130A (fr)
PT (1) PT1509241E (fr)
WO (1) WO2003099317A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19740030A1 (de) * 1997-09-11 1999-03-18 Knoell Hans Forschung Ev Ampullosporin, Verfahren zu dessen Herstellung und dessen Verwendung
DE19920816A1 (de) * 1999-05-05 2000-11-09 Aventis Pharma Gmbh Cephaibole, neue Antiparasitika aus Acremonium tubakii, Verfahren zu ihrer Herstellung und Verwendung derselben
DE19948644A1 (de) * 1999-10-01 2001-04-05 Knoell Hans Forschung Ev Neue Peptaibole mit neuroleptischer Wirkung

Also Published As

Publication number Publication date
PT1509241E (pt) 2007-01-31
BR0311238A (pt) 2005-03-15
JP2005528421A (ja) 2005-09-22
CA2487246A1 (fr) 2003-12-04
EP1679081A2 (fr) 2006-07-12
MXPA04011130A (es) 2005-08-15
EP1509241A1 (fr) 2005-03-02
EP1509241B1 (fr) 2006-08-16
WO2003099317A1 (fr) 2003-12-04
ATE336259T1 (de) 2006-09-15
DE50304667D1 (de) 2006-09-28
DE10222792A1 (de) 2003-12-04
ES2271575T3 (es) 2007-04-16
EP1679081A3 (fr) 2006-08-02
AU2003229766A1 (en) 2003-12-12

Similar Documents

Publication Publication Date Title
PE20080339A1 (es) Polipeptidos del factor de coagulacion ix modificados y uso de los mismos para tratamiento
JP2005528401A5 (fr)
ES2721172T3 (es) Una nueva clase de moléculas terapéuticas a base de proteínas
CY1108137T1 (el) Συνθεση για εισπνευστηρα δοσομετρημενης δοσης που χρησιμοποιει υδρο-φθορο-αλκανια ως προωθητικα
RU2008136324A (ru) Желудочно-кишечный пролиферативный фактор и его применения
PT99068B (pt) Processo para a preparacao de agentes antitromboticos tripeptidicos
NO20050537L (no) Anvendelse av HMGB1 i behandlingen av vevsskade og/eller for a fremme vevsreparasjon
ES2160485B1 (es) Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
ES2421447T3 (es) Métodos para proteger frente a apoptosis usando lipopéptidos
ES2125225T3 (es) Amidas de peptidos, procedimiento para su preparacion y agentes que las contienen como inhibidores de la coagulacion de fibrina/trombina.
PT95582B (pt) Processo para a preparacao de compostos peptidicos antagonistas do receptor do fibrinogenio
CO6260099A2 (es) Depsipeptidos ciclicos
CO5680457A2 (es) Moleculas de union de nogo-a y uso farmaceutico de las mismas
BR0116122A (pt) Peptìdeos e/ou proteìnas bem como seu uso para preparar uma composição farmacêutica, terapêutica e/ou preventiva
DE50105373D1 (de) Dipeptidische hemmstoffe für den gerinnungsfaktor xa
BRPI0302496C1 (pt) composições farmacêuticas com atividade antibiótica
DK1509241T3 (da) Nye anvendelser af cephaiboler
FR2846883B1 (fr) Composition cosmetique comprenant, comme ingredient actif, au moins un peptide et utilisation de ce peptide
FR2915397B1 (fr) Composition pharmaceutique et/ou cosmetique contenant des principes actifs activateurs de l'aconitase
DE60031422D1 (de) Peptidanaloge als selektive inhibitoren der thrombinaktivierung des durch protease aktivierten rezeptors
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
EA200501557A1 (ru) Новый способ синтеза (2s)-индолин-2-карбоновой кислоты и использование в синтезе периндоприла
EA200300483A1 (ru) Ингаляционная композиция в виде раствора с солью тиотропия
ATE510008T1 (de) Entzündungshemmende peptide
RU2010130763A (ru) Способы и фармакологические композиции для заживления ран